Recent advances and clinical outcomes of kidney transplantation

C Thongprayoon, P Hansrivijit, N Leeaphorn… - Journal of Clinical …, 2020 - mdpi.com
Recent advances in surgical, immunosuppressive and monitoring protocols have led to the
significant improvement of overall one-year kidney allograft outcomes. Nonetheless, there …

Circular RNA-regulated autophagy is involved in cancer progression

X Zhou, J Lin, F Wang, X Chen, Y Zhang… - Frontiers in Cell and …, 2022 - frontiersin.org
Circular RNAs (circRNAs) are a sort of long, non-coding RNA molecules with a covalently
closed continuous ring structure without 5'-3'polarity and poly-A tail. The modulative role of …

Promises of big data and artificial intelligence in nephrology and transplantation

C Thongprayoon, W Kaewput, K Kovvuru… - Journal of clinical …, 2020 - mdpi.com
Kidney diseases form part of the major health burdens experienced all over the world.
Kidney diseases are linked to high economic burden, deaths, and morbidity rates. The great …

Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation

L Yan, G Liu, H Cao, H Zhang, F Shao - Biochemical and biophysical …, 2019 - Elsevier
Renal clear cell carcinoma (RCC) is the most common pathological type of renal carcinoma
and drug resistance often occurs. We studied the effect of hsa_circ_0035483 on …

Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function

Ł Mielczarek, A Brodziak, P Sobczuk… - Cancer Chemotherapy …, 2021 - Springer
The introduction of novel targeted therapies during the last 2 decades has led to a significant
improvement in patients' clinical outcomes with renal cell carcinoma. However, this …

Use of dual-energy CT for renal mass assessment

S Thiravit, C Brunnquell, LM Cai, M Flemon… - European Radiology, 2021 - Springer
Although dual-energy CT (DECT) may prove useful in a variety of abdominal imaging tasks,
renal mass evaluation represents the area where this technology can be most impactful in …

Thermoablative Treatment of De Novo Tumor in Kidney Allograft

S Bodard, I Boudhabhay, C Dariane, C Delavaud… - …, 2024 - journals.lww.com
Background. The overall cancer risk increases in transplant patients, including in kidney
allografts. This study aimed to analyze the outcome of patients with kidney allograft …

[HTML][HTML] Role for contrast-enhanced ultrasound in assessing complications after kidney transplant

G Como, J Da Re, GL Adani, C Zuiani… - World Journal of …, 2020 - ncbi.nlm.nih.gov
Kidney transplantation (KT) is an effective treatment for end-stage renal disease. Despite
their rate has reduced over time, post-transplant complications still represent a major clinical …

Cancer screening in solid organ transplant recipients: a focus on screening liver, lung, and kidney recipients for cancers related to the transplanted organ

A Dharia, J Boulet, VS Sridhar, A Kitchlu - Transplantation, 2022 - journals.lww.com
Over the last few decades, the life expectancy of solid organ transplant recipients (SOTRs)
has improved significantly. With SOTRs living longer, more recipients are dying from cancer …

Ampelopsin inhibits cell viability and metastasis in renal cell carcinoma by negatively regulating the PI3K/AKT signaling pathway

Z Zhao, Y Jiang, Z Liu, Q Li, T Gao… - Evidence‐Based …, 2021 - Wiley Online Library
Background. Previous studies have shown that Ampelopsin has an inhibitory effect on
human tumors. However, the effect of Ampelopsin on renal cell carcinoma (RCC) is rarely …